Quantum-Si (NASDAQ:QSI) Trading Down 2.7% – Here’s Why

Quantum-Si Incorporated (NASDAQ:QSI)’s stock price fell 2.7% during mid-day trading on Friday . The company traded as low as $0.9332 and last traded at $0.9467. 3,303,668 shares traded hands during trading, a decline of 48% from the average session volume of 6,382,231 shares. The stock had previously closed at $0.9730.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on QSI. Canaccord Genuity Group lowered their target price on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating on the stock in a report on Wednesday, March 4th. Weiss Ratings reissued a “sell (d-)” rating on shares of Quantum-Si in a research report on Friday, March 27th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Reduce” and a consensus target price of $1.00.

Quantum-Si Stock Down 2.7%

The stock has a market capitalization of $206.15 million, a price-to-earnings ratio of -1.86 and a beta of 3.18. The business’s 50 day simple moving average is $0.96 and its 200-day simple moving average is $1.06.

Quantum-Si (NASDAQ:QSI) last announced its quarterly earnings data on Thursday, May 7th. The company reported ($0.10) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.02. The firm had revenue of $0.26 million for the quarter, compared to the consensus estimate of $0.30 million. Quantum-Si had a negative net margin of 5,605.88% and a negative return on equity of 47.35%. On average, analysts expect that Quantum-Si Incorporated will post -0.49 earnings per share for the current year.

Insider Transactions at Quantum-Si

In other Quantum-Si news, CFO Jeffry R. Keyes sold 37,381 shares of the stock in a transaction dated Tuesday, April 21st. The shares were sold at an average price of $0.99, for a total transaction of $37,007.19. Following the sale, the chief financial officer directly owned 1,732,582 shares in the company, valued at $1,715,256.18. This represents a 2.11% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Jeffrey Alan Hawkins sold 83,712 shares of the stock in a transaction dated Monday, April 20th. The stock was sold at an average price of $1.01, for a total transaction of $84,549.12. Following the sale, the chief executive officer owned 3,776,135 shares in the company, valued at $3,813,896.35. The trade was a 2.17% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 212,904 shares of company stock worth $205,021 over the last quarter. Corporate insiders own 22.04% of the company’s stock.

Institutional Trading of Quantum-Si

Large investors have recently bought and sold shares of the business. Prudential Financial Inc. bought a new position in Quantum-Si in the second quarter valued at about $25,000. Curbstone Financial Management Corp bought a new position in Quantum-Si in the fourth quarter valued at about $26,000. Leonteq Securities AG bought a new position in Quantum-Si in the fourth quarter valued at about $28,000. Cerity Partners LLC bought a new position in Quantum-Si in the second quarter valued at about $29,000. Finally, Hollencrest Capital Management grew its position in Quantum-Si by 301.1% in the first quarter. Hollencrest Capital Management now owns 40,111 shares of the company’s stock valued at $31,000 after acquiring an additional 30,111 shares during the last quarter. 39.90% of the stock is owned by institutional investors and hedge funds.

About Quantum-Si

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.